18F-Fluorocholine for the Detection of Parathyroid Adenomas

18F-Fluorocholine for the Detection of Parathyroid Adenomas

The investigators are studying the ability of F18 labeled fluorocholine PET to localize parathyroid adenomas in patients with hyperparathyroidism prior to surgery.

Inclusion Criteria:

• Biochemically proven hyperparathyroidism and an indication for surgery
• Age >= 13 years old
• Karnofsky performance status of > 50 (or Eastern Cooperative Oncology Group (ECOG)/World Health Organization (WHO) equivalent).
• Ability to understand a written informed consent document, and the willingness to sign it.

Exclusion Criteria:

• Patients exceeding the weight limitations of the scanner or are not able to enter the bore of the PET scanner due to BMI.
• Inability to lie still for the entire imaging time (e.g. cough, severe arthritis, etc.).
• Inability to complete the needed investigational due to other reasons (severe claustrophobia, radiation phobia, etc.).
• Pregnancy.